![Fritz R. Buhler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fritz R. Buhler
Corporate Officer/Principal chez University Hospital of Boston
Postes actifs de Fritz R. Buhler
Sociétés | Poste | Début | Fin |
---|---|---|---|
University Hospital of Boston | Corporate Officer/Principal | - | - |
Historique de carrière de Fritz R. Buhler
Anciens postes connus de Fritz R. Buhler
Sociétés | Poste | Début | Fin |
---|---|---|---|
Bear Stearns Health Innoventures Management LLC
![]() Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Private Equity Investor | - | 30/09/2007 |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - | - |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
International Biomedicine Management Partners AG | Directeur/Membre du Conseil | - | - |
Corus Pharma, Inc.
![]() Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - | - |
AGY Therapeutics, Inc.
![]() AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - | - |
Formation de Fritz R. Buhler
University of Basel | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Suisse | 3 |
Opérationnelle
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Private Equity Investor | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 4 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 6 |
---|---|
Bear Stearns Health Innoventures Management LLC
![]() Bear Stearns Health Innoventures Management LLC Investment ManagersFinance A subsidiary of Bear Stearns Asset Management, Inc., Bear Stearns Health Innoventures Management LLC (BSHI) is a venture capital firm headquartered in New York City. | Finance |
AGY Therapeutics, Inc.
![]() AGY Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AGY Therapeutics, Inc. develops new therapies for diseases and disorders. It develops central nervous system therapeutics for the treatments of neurodegenerative diseases, CNS injuries, stroke, and schizophrenia. The company was founded by Robert Swanson and Karoly Nikolich in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
University Hospital of Boston | |
Corus Pharma, Inc.
![]() Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | Health Technology |
International Biomedicine Management Partners AG | Finance |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Bourse
- Insiders
- Fritz R. Buhler
- Expérience